Roberto Fino

Roberto Fino

Auto-generated profile, based on publicly available information

Roberto Fino

Acellera Labs SL

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2023 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
RGRaimondas Galvelis
Raimondas Galvelis
AVAlejandro Varela-Rial
Alejandro Varela-Rial
SDStefan Doerr
Stefan Doerr
RFRoberto Fino
Roberto Fino
PEPeter Eastman
Peter Eastman
GFGianni De Fabritiis
Gianni De Fabritiis

26 August 2016 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
Stefano PiottoStefano Piotto
Stefano Piotto
LBL. Di Biasi
L. Di Biasi
RFR. Fino
R. Fino
RPR. Parisi
R. Parisi
Lucia SessaLucia Sessa
Lucia Sessa
Simona ConcilioSimona Concilio
Simona Concilio

1 October 2021 in Journal of Chemical Information and Modeling
Verified
Journal Article
Open access
RFRoberto Fino
Roberto Fino
DLDominik Lenhart
Dominik Lenhart
VKVishal C. Kalel
Vishal C. Kalel
CSCharlotte A. Softley
Charlotte A. Softley
VNValeria Napolitano
Valeria Napolitano
GPGrzegorz M. Popowicz
Grzegorz M. Popowicz
African and American trypanosomiases are estimated to affect several million people across the world, with effective treatments distinctly lacking. New, ideally oral, treatments with higher efficacy against these diseases are desperately needed. Peroxisomal import matrix (PEX) proteins represent a very interesting target for structure- and ligand-based drug design. The PEX5–PEX14 protein–protein interface in particular has been highlighted as a target, with inhibitors shown to disrupt essential cell processes in trypanosomes, leading to cell death. In this work, we present a drug development campaign that utilizes the synergy between structural biology, computer-aided drug design, and medicinal chemistry in the quest to discover and develop new potential compounds to treat trypanosomiasis by targeting the PEX14–PEX5 interaction. Using the structure of the known lead compounds discovered by Dawidowski et al. as the template for a chemically advanced template search (CATS) algorithm, we performed scaffold-hopping to obtain a new class of compounds with trypanocidal activity, based on 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepines chemistry. The initial compounds obtained were taken forward to a first round of hit-to-lead optimization by synthesis of derivatives, which show activities in the range of low- to high-digit micromolar IC50 in the in vitro tests. The NMR measurements confirm binding to PEX14 in solution, while immunofluorescent microscopy indicates disruption of protein import into the glycosomes, indicating that the PEX14–PEX5 protein–protein interface was successfully disrupted. These studies result in development of a novel scaffold for future lead optimization, while ADME testing gives an indication of further areas of improvement in the path from lead molecules toward a new drug active against trypanosomes.

28 August 2023 in arXiv
Verified
Preprint
Open access
PDF file
RGRaimondas Galvelis
Raimondas Galvelis
AVAlejandro Varela-Rial
Alejandro Varela-Rial
SDStefan Doerr
Stefan Doerr
RFRoberto Fino
Roberto Fino
PEPeter Eastman
Peter Eastman
GFGianni De Fabritiis
Gianni De Fabritiis
Machine learning potentials have emerged as a means to enhance the accuracy of biomolecular simulations. However, their application is constrained by the significant computational cost arising from the vast number of parameters compared to traditional molecular mechanics. To tackle this issue, we introduce an optimized implementation of the hybrid method (NNP/MM), which combines neural network potentials (NNP) and molecular mechanics (MM). This approach models a portion of the system, such as a small molecule, using NNP while employing MM for the remaining system to boost efficiency. By conducting molecular dynamics (MD) simulations on various protein-ligand complexes and metadynamics (MTD) simulations on a ligand, we showcase the capabilities of our implementation of NNP/MM. It has enabled us to increase the simulation speed by 5 times and achieve a combined sampling of one microsecond for each complex, marking the longest simulations ever reported for this class of simulation.

20 March 2024 in eLife preprints
Verified
Preprint
Open access
MPMarcel Proske
Marcel Proske
RJRobert Janowski
Robert Janowski
SBSabrina Bacher
Sabrina Bacher
HKHyun-Seo Kang
Hyun-Seo Kang
TMThomas Monecke
Thomas Monecke
DNDierk Niessing
Dierk Niessing
Mutations in the human PURA gene cause the neuro-developmental PURA syndrome. In contrast to several other mono-genetic disorders, almost all reported mutations in this nucleic acid binding protein result in the full disease penetrance. In this study, we observed that patient mutations across PURA impair its previously reported co-localization with processing bodies. These mutations either destroyed the folding integrity, RNA binding or dimerization of PURA. We also solved the crystal structures of the N- and C-terminal PUR domains of human PURA and combined them with molecular dynamics simulations and NMR measurements. The observed unusually high dynamics and structural promiscuity of PURA indicated that this protein is particularly susceptible to mutations impairing its structural integrity. It offers an explanation why even conservative mutations across PURA result in the full penetrance of symptoms in patients with PURA syndrome.

20 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MPMarcel Proske
Marcel Proske
RJRobert Janowski
Robert Janowski
SBSabrina Bacher
Sabrina Bacher
HKHyun-Seo Kang
Hyun-Seo Kang
TMThomas Monecke
Thomas Monecke
DNDierk Niessing
Dierk Niessing
Mutations in the human PURA gene cause the neuro-developmental PURA syndrome. In contrast to several other mono-genetic disorders, almost all reported mutations in this nucleic acid binding protein result in the full disease penetrance. In this study, we observed that patient mutations across PURA impair its previously reported co-localization with processing bodies. These mutations either destroyed the folding integrity, RNA binding or dimerization of PURA. We also solved the crystal structures of the N- and C-terminal PUR domains of human PURA and combined them with molecular dynamics simulations and NMR measurements. The observed unusually high dynamics and structural promiscuity of PURA indicated that this protein is particularly susceptible to mutations impairing its structural integrity. It offers an explanation why even conservative mutations across PURA result in the full penetrance of symptoms in patients with PURA syndrome.